array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "Gsk Consumer Health, Inc." ["slug"]=> string(32) "4abba-us-gsk-consumer-health-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204" ["description"]=> string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company." ["address_street"]=> string(28) "184 Liberty Corner Rd Ste 78" ["address_place"]=> string(6) "Warren" ["address_region"]=> string(10) "New Jersey" ["founding_date"]=> string(10) "1994-02-28" ["website_domain"]=> string(7) "gsk.com" ["website_url"]=> string(19) "https://www.gsk.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(300) ["article_count"]=> int(451) } ["articles"]=> array(6) { [0]=> array(7) { ["title_en"]=> string(114) "The new European pharmaceutical legislation could improve access to medicines but a political consensus is lacking" ["snippet_en"]=> string(104) "The review of European pharmaceutical legislation, proposed by the European Commission in April 2023,..." ["url"]=> string(160) "https://www.infosalus.com/farmacia/noticia-nueva-legislacion-farmaceutica-europea-podria-mejorar-acceso-medicamentos-falta-consenso-politico-20240212153556.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8af37388-ca63-40f4-9fd5-34f396234309" ["source"]=> string(13) "infosalus.com" ["publication_date"]=> string(10) "2024-02-12" ["categories"]=> array(4) { [0]=> string(46) "Management of Legal and Regulatory Environment" [1]=> string(13) "Collaboration" [2]=> string(22) "EU Political Evolution" [3]=> string(11) "Legislation" } } [1]=> array(7) { ["title_en"]=> string(83) "Legal Battle: GSK Sues Pfizer and BioNTech for COVID-19 Vaccine Patent Infringement" ["snippet_en"]=> string(157) "GlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging that the companies’ COVID-19 vaccines, Comirnaty," ["url"]=> string(108) "https://newswherever.com/legal-battle-gsk-sues-pfizer-and-biontech-for-covid-19-vaccine-patent-infringement/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/5caeac9c-2562-45fe-bd7a-85cd8a9780a3" ["source"]=> string(16) "newswherever.com" ["publication_date"]=> string(10) "2024-02-04" ["categories"]=> array(7) { [0]=> string(8) "Epidemic" [1]=> string(8) "Verdicts" [2]=> string(17) "Business Disputes" [3]=> string(46) "Management of Legal and Regulatory Environment" [4]=> string(21) "Intellectual Property" [5]=> string(10) "Litigation" [6]=> string(5) "Legal" } } [2]=> array(7) { ["title_en"]=> string(65) "GSK Agrees to Settle Robitussin ‘Non-Drowsy’ False-Ad Lawsuit" ["snippet_en"]=> string(209) "GSK Consumer Health Inc. and consumers who alleged it deceptively marketed Robitussin cough medicines as “non-drowsy” have agreed in principle to a classwide settlement, according to a recent court filing." ["url"]=> string(111) "https://news.bloomberglaw.com/business-and-practice/gsk-agrees-to-settle-robitussin-non-drowsy-false-ad-lawsuit" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b0397ad4-50dd-481b-af4d-b15cf41c99a7" ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> string(10) "2023-11-20" ["categories"]=> array(5) { [0]=> string(46) "Management of Legal and Regulatory Environment" [1]=> string(16) "Case Settlements" [2]=> string(15) "Business Ethics" [3]=> string(5) "Legal" [4]=> string(16) "Customer Welfare" } } [3]=> array(7) { ["title_en"]=> string(67) "Robitussin Consumers Want ‘Non-Drowsy’ False-Ad Suit Reinstated" ["snippet_en"]=> string(171) "Robitussin users told an appeals court that federal law doesn’t block their claims that GSK Consumer Health Inc. deceptively advertises “non-drowsy” cough medicines." ["url"]=> string(124) "https://news.bloomberglaw.com/product-liability-and-toxics-law/robitussin-consumers-want-non-drowsy-false-ad-suit-reinstated" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a03874df-9da5-494e-8135-b154c5ddc8b9" ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> string(10) "2023-06-30" ["categories"]=> array(4) { [0]=> string(8) "Verdicts" [1]=> string(46) "Management of Legal and Regulatory Environment" [2]=> string(17) "Consumer Behavior" [3]=> string(5) "Legal" } } [4]=> array(7) { ["title_en"]=> string(6) "Detail" ["snippet_en"]=> string(129) "Daily current reports on deals, personal details and proceedings from business consulting law firms and company legal departments" ["url"]=> string(67) "https://www.lto.de/kanzleien-unternehmen/transfermarkt/detail/4521/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/952ca27b-4ccc-4631-8358-873793e931a4" ["source"]=> string(6) "lto.de" ["publication_date"]=> string(10) "2023-04-04" ["categories"]=> array(2) { [0]=> string(46) "Management of Legal and Regulatory Environment" [1]=> string(5) "Legal" } } [5]=> array(7) { ["title_en"]=> string(64) "GSK Consumer Health $6.5 Million Benefiber False Ad Deal Gets OK" ["snippet_en"]=> string(200) "A $6.5 million nationwide class settlement between GSK Consumer Health Inc. and customers alleging it deceptively marketed certain Benefiber products got the initial nod from a New York federal court." ["url"]=> string(106) "https://news.bloomberglaw.com/class-action/gsk-consumer-health-6-5-million-benefiber-false-ad-deal-gets-ok" ["image_url"]=> string(78) "https://images.businessradar.com/articles/277eca4d-d033-4ddd-ad76-f841866de55f" ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> string(10) "2021-06-09" ["categories"]=> array(4) { [0]=> string(10) "Litigation" [1]=> string(16) "Case Settlements" [2]=> string(46) "Management of Legal and Regulatory Environment" [3]=> string(5) "Legal" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(28) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(27) } [2]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [3]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(21) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(20) } [5]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(18) } [6]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(17) } [7]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(17) } [8]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(15) } [9]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(14) } [10]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(14) } [11]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(14) } [12]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(12) } [13]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(11) } [14]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(10) } [15]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(10) } [16]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(8) } [19]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(6) } [22]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(6) } [23]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(6) "Crisis" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(6) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(6) } [28]=> array(2) { ["name"]=> string(24) "Employee Health & Safety" ["count"]=> int(6) } [29]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(5) } } } 4abba-us-gsk-consumer-health-inc